To test the contribution of M-CSF production by p53-null cells to the modulation of the T cell response in vivo, we treated immunocompetent mice challenged with either p53WT or p53-null tumor cells with neutralizing antibodies against CSF1R, the receptor for M-CSF (Figure 4A). Here, CSF1 is linked to neoplasm.